Cytosorbents
CTSO · NASDAQ
$5.32+$0.36 (+7.26%)TodayMarket closed ·
Prev close $4.96
Who owns CTSO
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 34.7% of CTSO’s shares.
- Avenir Corporation8.3%
- Rokk LLC7.3%
- Satterfield (Thomas A Jr)4.6%
- Neuberger Berman, LLC3.1%
- Next 6 largest institutions11.5%
- All other shareholders65.3%
| Holder | Shares | % of shares |
|---|---|---|
| Avenir Corporation | 5.19M | 8.26% |
| Rokk LLC | 4.58M | 7.29% |
| Satterfield (Thomas A Jr) | 2.89M | 4.59% |
| Neuberger Berman, LLC | 1.97M | 3.13% |
| Vanguard Capital Management, LLC | 1.91M | 3.05% |
| CM Management, LLC | 1.48M | 2.35% |
| Chan (Phillip P) | 1.37M | 2.19% |
| Skylands Capital, LLC | 1.21M | 1.93% |
| BlackRock Institutional Trust Company, N.A. | 627.21K | 1.00% |
| Geode Capital Management, L.L.C. | 602.06K | 0.96% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| Vanguard Total Stock Market Index Fund | 63.72K | 0.10% |
| Neuberger Intrinsic Value Fund | 32.33K | 0.05% |
| Vanguard Extended Market Index Fund | 28.72K | 0.05% |
| Fidelity Extended Market Index Fund | 14.61K | 0.02% |
| Fidelity Total Market Index Fund | 4.72K | 0.01% |
Insider trades
Form 4 filings by officers, directors and large holders
Over the last 6 months, insiders bought $269.33K (10 trades) of CTSO on the open market, with no sales.
| Insider | Type | Shares | Value |
|---|---|---|---|
| Chan Phillip P. | Buy | 3.77K | $22.64K |
| Sobel Alan D. | Buy | 100 | $601 |
| Sobel Alan D. | Buy | 500 | $3.03K |
| Sobel Alan D. | Buy | 1.90K | $11.63K |
| Capponi Vincent | Buy | 273 | $1.61K |
| Capponi Vincent | Buy | 1.80K | $10.93K |
| Chan Phillip P. | Buy | 200.00K | $70.00K |
| MARIANI PETER J | Buy | 100.00K | $44.00K |
| Chan Phillip P. | Buy | 10.33K | $4.44K |
| Chan Phillip P. | Buy | 251.14K | $100.45K |
Short interest
Settled Sep 30, 2026
- Shares short
- 123.89K
- Days to cover
- 11.98
- % of shares outstanding
- 0.20%
- Average daily volume
- 10.34K
- Change since last report
- +2.7%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.